American Journal of Clinical Pathology · 2004 · 92 citations · 37 references
MedicineHematologyOncologyCytogeneticsHematologic OncologyHematopathologyBone Marrow PathologyCancer CytogeneticsClinical CytogeneticsHematologic MalignanciesHematopoietic NeoplasmsMolecular CytogeneticsAcute LeukemiasCytogenetic AberrationsCytogenetics In Hematologic DiseaseFlt3 Gene RearrangementLeukemia ClassificationLeukemia CytogeneticsMedian AgeWorld Health Organization Histologic Classification
We report 12 cases of t(6;9)(p23;q34)-positive acute myeloid leukemia (AML), all classified using the criteria of the World Health Organization classification. There were 10 women and 2 men with a median age of 51 years (range, 20-76 years). Dysplasia was present in all cases (9 previously untreated), and basophilia was present in 6 (50%). Immunophenotypic studies showed that the blasts were positive for CD9, CD13, CD33, CD38, CD117, and HLA-DR in all cases assessed. CD34 was positive in 11 (92%) of 12, and terminal deoxynucleotidyl transferase was positive in 7 (64%) of 11 cases. The t(6;9) was the only cytogenetic abnormality detected in 7 cases (58%), and 5 cases had additional chromosomal abnormalities. Of 8 cases assessed, 7 (88%) had flt3 gene mutations. We conclude that t(6;9)-positive AML cases have distinctive morphologic features, an immunophenotype suggesting origin from an early hematopoietic progenitor cell, and a high frequency of flt3 gene mutations.
37
ISCN 1995 An international system for human cytogenetic nomenclature
Felix Mitelman · 1995 · 1.9K citations
Life Sciences, Biology, Genetics +10
Christian Thiede, Christine Steudel, Brigitte Mohr et al. · Blood · 2002 · 1.7K citations · Full text
Medicine, Genetics, Hematology +14
Susanne Schnittger, Claudia Schoch, Martin Dugas et al. · Blood · 2002 · 964 citations · Full text
Medicine, Hematology, Oncology +17
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
Hitoshi Kiyoi, Tomoki Naoe, Yasuyuki Nakano et al. · PubMed · 1999 · 765 citations